scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00432-015-1991-5 |
P698 | PubMed publication ID | 26013424 |
P50 | author | Gerald Antoch | Q110980843 |
P2093 | author name string | Nikolaus Becker | |
Peter Albers | |||
Helmut E Gabbert | |||
Robert Rabenalt | |||
Christian Arsov | |||
Michael Quentin | |||
Frederic Dietzel | |||
Lars Schimmöller | |||
Andreas Hiester | |||
P2860 | cites work | Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. | Q45967722 |
Association between percentage of tumor involvement and Gleason score upgrading in low-risk prostate cancer | Q47635662 | ||
Radiotherapy and short-term androgen deprivation for localized prostate cancer. | Q51021354 | ||
Prostate needle biopsies: interobserver variation and clinical consequences of histopathological re-evaluation. | Q51578950 | ||
Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy. | Q53304507 | ||
Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy--should we reassess our practices for antibiotic prophylaxis? | Q54351950 | ||
A biopsy simulation study to assess the accuracy of several transrectal ultrasonography (TRUS)-biopsy strategies compared with template prostate mapping biopsies in patients who have undergone radical prostatectomy | Q63966214 | ||
Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection | Q63966218 | ||
Prognostic factors in men with stage D1 prostate cancer: identification of patients less likely to have prolonged survival after radical prostatectomy. | Q64966358 | ||
Prostate biopsy grading errors: a sampling problem? | Q73444033 | ||
Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancer | Q74325627 | ||
Comparing the Gleason prostate biopsy and Gleason prostatectomy grading system: the Lahey Clinic Medical Center experience and an international meta-analysis | Q81036362 | ||
Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy | Q81280205 | ||
Impact of a tertiary Gleason pattern 4 or 5 on clinical failure and mortality after radical prostatectomy for clinically localised prostate cancer | Q84967080 | ||
Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen | Q87965125 | ||
ESUR prostate MR guidelines 2012 | Q24620926 | ||
The role of magnetic resonance imaging in the diagnosis and management of prostate cancer | Q26849794 | ||
Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathology | Q34364108 | ||
Gleason grading of prostate cancer: level of concordance between pathologists at the University Hospital of the West Indies | Q35885016 | ||
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma | Q36227180 | ||
The potential impact of reproducibility of Gleason grading in men with early stage prostate cancer managed by active surveillance: a multi-institutional study | Q37890605 | ||
Active surveillance for prostate cancer: a systematic review of the literature | Q38018748 | ||
EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. | Q38160994 | ||
Low-risk prostate cancer: the accuracy of multiparametric MR imaging for detection | Q38183902 | ||
Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial | Q38392753 | ||
Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores | Q40114797 | ||
Predicting extracapsular extension of prostate cancer in men treated with radical prostatectomy: results from the population based prostate cancer outcomes study | Q41691247 | ||
Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. | Q43467766 | ||
A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial | Q43493324 | ||
MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy | Q44119084 | ||
25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution series | Q44921443 | ||
Targeted MRI-guided prostate biopsies for the detection of prostate cancer: initial clinical experience with real-time 3-dimensional transrectal ultrasound guidance and magnetic resonance/transrectal ultrasound image fusion | Q44944586 | ||
Presence of high grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence-free survival. | Q45412507 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2061-2068 | |
P577 | publication date | 2015-05-27 | |
P1433 | published in | Journal of Cancer Research and Clinical Oncology | Q2081599 |
P1476 | title | The use of targeted MR-guided prostate biopsy reduces the risk of Gleason upgrading on radical prostatectomy | |
P478 | volume | 141 |
Q50104969 | 1.0T MR-guided percutaneous coaxial cutting needle biopsy in pancreatic lesion diagnosis |
Q52674710 | Can Prostate Imaging Reporting and Data System Version 2 reduce unnecessary prostate biopsies in men with PSA levels of 4-10 ng/ml? |
Q57493742 | Comparison of Gleason upgrading rates in transrectal ultrasound systematic random biopsies versus US-MRI fusion biopsies for prostate cancer |
Q95261579 | Evolution of prostate cancer diagnosis: retrospective analysis of magnetic resonance imaging/ultrasound fusion guided biopsies protocol in routine practice and patients management |
Q48025252 | External validation and comparison of two nomograms predicting the probability of Gleason sum upgrading between biopsy and radical prostatectomy pathology in two patient populations: a retrospective cohort study |
Q57725405 | How Would MRI-targeted Prostate Biopsy Alter Radiation Therapy Approaches in Treating Prostate Cancer? |
Q60923446 | Imaging as a Personalized Biomarker for Prostate Cancer Risk Stratification |
Q57111662 | Impact of multiparametric MRI and MRI-targeted biopsy on pre-therapeutic risk assessment in prostate cancer patients candidate for radical prostatectomy |
Q51471939 | MR-guided percutaneous biopsy of solitary pulmonary lesions using a 1.0-T open high-field MRI scanner with respiratory gating. |
Q96813857 | Pathological findings at radical prostatectomy of biopsy naïve men diagnosed with MRI targeted biopsy alone without concomitant standard systematic sampling |
Q40463189 | Preoperative low serum testosterone is associated with high-grade prostate cancer and an increased Gleason score upgrading. |
Q38779933 | Recent advances in prostate cancer pathology: Gleason grading and beyond |
Q57493779 | Risk of upgrading from prostate biopsy to radical prostatectomy pathology: Is magnetic resonance imaging-guided biopsy more accurate? |
Q53630425 | Targeted MRI-guided prostate biopsy: are two biopsy cores per MRI-lesion required? |
Q50088856 | The Current State of MR Imaging-targeted Biopsy Techniques for Detection of Prostate Cancer. |
Q38795731 | Use of mpMRI in active surveillance for localized prostate cancer |
Q33580964 | Utilization of multiparametric prostate magnetic resonance imaging in clinical practice and focal therapy: report from a Delphi consensus project |